Jackson Square Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$5.96M |
| 2 |
Marvell Technology
MRVL
|
+$5.84M |
| 3 |
Boston Scientific
BSX
|
+$5.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63M |
| 5 |
NVIDIA
NVDA
|
+$5.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.54M |
| 2 |
Mastercard
MA
|
+$3.5M |
| 3 |
T-Mobile US
TMUS
|
+$2.62M |
| 4 |
SPDR Gold Trust
GLD
|
+$2.42M |
| 5 |
Howmet Aerospace
HWM
|
+$2.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.02% |
| 2 | Communication Services | 11.43% |
| 3 | Healthcare | 8.43% |
| 4 | Industrials | 7.53% |
| 5 | Consumer Discretionary | 6.31% |
Similar funds
Jackson Square Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Jackson Square Capital held 167 positions worth $450M, up 46% from $308M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Jackson Square Capital deployed $78.4M of net new capital in Q2 2025, opening 35 new positions and adding to 47 existing holdings. Its largest new stake was Invesco NASDAQ 100 ETF: 29,086 shares worth $6.61M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 39% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $4.54M trimmed.
- Jackson Square Capital's largest Q2 2025 buy was Invesco NASDAQ 100 ETF: 29,086 shares worth $6.61M.
- Jackson Square Capital added most to Marvell Technology in Q2 2025, an estimated $5.84M increase.
- Jackson Square Capital's biggest Q2 2025 reduction was Apple, cutting an estimated $4.54M.
- Jackson Square Capital fully exited Howmet Aerospace in Q2 2025, selling an estimated $2.06M.
- Jackson Square Capital's ten largest holdings make up 37% of its $450M portfolio in Q2 2025.
- Jackson Square Capital opened 35 new positions and closed 21 in Q2 2025.
- Jackson Square Capital's portfolio value rose 46% quarter-over-quarter to $450M.
Based on Jackson Square Capital's 13F filing for Q2 2025, filed 10 Jul 2025.